Long-term use of clonidine in a critically-ill infant

Rebecca Lowery1, Jeannie Zuk, David M Polaner

  • 1Department of Anesthesiology, The Children's Hospital, Denver, CO 80218, USA. lowery.rebecca@tchden.org

Insights

Clonidine effectively aided sedation and pain relief in an infant for over four months in critical care. This report details its benefits, risks, and administration methods for pediatric intensive care.

Area of Science:

  • Pediatric critical care medicine
  • Pharmacology
  • Neonatal intensive care

Background:

  • Sedation and analgesia are crucial for managing critically ill infants.
  • Optimizing pain and anxiety management in neonates is an ongoing challenge.
  • Exploring adjunct therapies can improve patient outcomes and reduce opioid use.

Observation:

  • Clonidine was administered to an infant for 4.5 months as part of a sedation and analgesia regimen.
  • The medication was used in a critical care setting, indicating its role in complex pediatric cases.
  • Multiple modes of delivery were employed, suggesting flexibility in its administration.

Findings:

  • Clonidine demonstrated utility as an adjunctive agent for sedation and analgesia in an infant.
  • The study discusses the advantages of using clonidine in this population.
  • Potential side effects and appropriate dosing strategies for various delivery methods are outlined.

Implications:

  • This case highlights clonidine as a potential option for prolonged sedation and analgesia in pediatric critical care.
  • Understanding its safety profile and dosing is essential for clinicians.
  • Further research may explore the long-term effects and broader applications of clonidine in neonates and infants.

Related Concept Videos

Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
Drugs in...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...